Invested in neurotechnology startups developing treatments and tools for neurological conditions, including brain-computer interfaces. The firm states that its operations concluded on March 31, 2026.
Founded
2023
Type
Venture capital
Funds1
Nexus NeuroTech Fund II, L.P.$126M
The March 20, 2025 SEC notice reports a $126 million offering fully sold to two investors, with the first sale on March 14, 2025.